- Report
- May 2022
- 63 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- July 2024
- 90 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2024
Global
From €3327EUR$3,500USD£2,795GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2614EUR$2,750USD£2,196GBP
- Report
- December 2021
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2022
- 247 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Report
- April 2022
- 200 Pages
Global
From €3389EUR$3,565USD£2,847GBP
The Syphilis Test market is a segment of the Infectious Disease Testing market. It is used to detect the presence of the bacterium Treponema pallidum, which causes syphilis. Tests for syphilis are typically conducted using a blood sample, and may also include a physical examination. The test is used to diagnose syphilis in individuals who are symptomatic, as well as to screen for the disease in those who are at risk. Treatment for syphilis is available, and early diagnosis is important for successful treatment.
The Syphilis Test market is comprised of a variety of companies, including Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, Ortho Clinical Diagnostics, Quidel, Roche Diagnostics, and Siemens Healthineers. Show Less Read more
